Relationship Between Methadone Induction Dosing and Retention in Treatment in Opioid Treatment Programs

Addiction Medicine: Beyond the Abstract

Content provided by American Society of Addiction Medicine. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by American Society of Addiction Medicine or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

27d ago 17:02

MP3•Episode home

Host Dr. Shawn McNeil is joined by Dr. Robert Sherrick to discuss his new article Relationship Between Methadone Induction Dosing and Retention in Treatment in Opioid Treatment Programs featured in the July/August issue of the Journal of Addiction Medicine.

Robert Sherrick, MD, DFASAM, is chief science officer for Community Medical Services, a company that serves patients through over 70 Opioid Treatment Programs in 12 states. He also has experience working at an inpatient addiction treatment facility, Pathways Treatment Center, treating all forms of substance use disorders and dual diagnosis patients.

Dr. Sherrick has been providing medication treatment for opioid use disorder since 2003, initially in an office setting using buprenorphine and subsequently with methadone in Opioid Treatment Programs. He established a state-wide buprenorphine treatment program for VA Montana with extensive use of telemedicine. He is board certified in internal medicine and addiction medicine through the American Board of Preventive Medicine. He is past president of the Northwest Chapter of the American Society of Addiction Medicine (ASAM).

Article: Relationship Between Methadone Induction Dosing and Retention in Treatment in Opioid Treatment Programs

46 episodes

#Science #Shawn McNeil #Shawn McNeil MD